Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Kim Mark Knudsen"'
Publikováno v:
Clinical Pharmacokinetics. 62:645-651
Autor:
Mikkel Askjær Agersnap, Kim Sonne, Kim Mark Knudsen, Carsten Boye Knudsen, Mark Berner-Hansen
Publikováno v:
Clinical Drug Investigation. 42:1093-1100
Glepaglutide is a novel, long-acting, glucagon-like peptide-2 analogue in a stable aqueous formulation for subcutaneous dosing to treat patients with short bowel syndrome. This study was conducted primarily to characterise the pharmacokinetics of gle
Publikováno v:
Clinical Pharmacokinetics. 62:653-654
Publikováno v:
Dermatologic Surgery. 43:424-430
Cryosurgery is the most commonly used method to treat actinic keratosis (AK). Cryosurgical methods are not standardized. To examine differences in the spray techniques used for liquid nitrogen cryosurgery when treating AKs of the head, and the effect
Publikováno v:
Journal of Dermatological Treatment. 27:450-455
Treatments for actinic keratosis (AK) can elicit adverse local skin responses (LSRs). Knowledge regarding the burden of AK treatment on health related quality of life (HRQoL) is however limited.To investigate whether treatment of AK improved HRQoL; t
Publikováno v:
Journal of drugs in dermatology : JDD. 16(2)
pIngenol mebutate gel, a topical field treatment for actinic keratosis (AK), elicits inflammatory application-site reactions in most patients. This analysis explored the relationship between the intensity of local skin reactions (LSRs) and AK clearan
Publikováno v:
Vinding, G R, Knudsen, K M, Ellervik, C, Olesen, A B & Jemec, G B E 2014, ' Self-reported skin morbidities and health-related quality of life : a population-based nested case-control study ', Dermatology, vol. 228, no. 3, pp. 261-8 . https://doi.org/10.1159/000358009
Background: Impaired dermatological health-related quality of life (HRQoL) has been observed in hospital-based studies, but little is known on a population-based level. Objective: To investigate self-reported dermatological HRQoL in the general popul
Publikováno v:
Clinical, Cosmetic and Investigational Dermatology
Shelbi C Jim On,1 Kim Mark Knudsen,2 Torsten Skov,2 Mark Lebwohl,1 1Department of Dermatology, Mount Sinai School of Medicine, New York, NY, USA; 2LEO Pharma A/S, Biostatistics, Ballerup, Denmark Background: Ingenol mebutate gel is a topical field tr
Autor:
Gabrielle R. Vinding, Kian Zarchi, Kristina S Ibler, I.M. Miller, Gregor B.E. Jemec, Kim Mark Knudsen, Christina Ellervik
Publikováno v:
JAMA dermatology. 150(12)
IMPORTANCE An association between the metabolic syndrome (MetS) and chronic inflammatory diseases, such as psoriasis or rheumatoid arthritis, has been suggested.Hidradenitis suppurativa (HS), a more localized chronic inflammation of the skin, has bee
Autor:
Brian, Berman, Gary, Goldenberg, C William, Hanke, Stephen K, Tyring, Wm Philip, Werschler, Kim Mark, Knudsen, Thomas, Larsson, Neil, Swanson
Publikováno v:
Journal of drugs in dermatology : JDD. 13(6)
Recurrence rates of actinic keratosis (AK) lesions after cryosurgery are high, and this treatment does not address field cancerization. We investigated the efficacy and safety of field treatment of AKs with ingenol mebutate gel following cryosurgery.